Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension

导出原文传递

翻译打印收藏纠错

作者： McLendon, Jared M. ^[1] ; Joshi, Sachindra R. ^[2] ; Sparks, Jeff ^[3] ; Matar, Majed ^[4] ; Fewell, Jason G. ^[2] ; Abe, Kohtaro ^[5] ; Oka, Masahiko ^[5] ; McMurtry, Ivan F. ^[5] ; Gerthoffer, William T. ^[2]

作者单位： Univ S Alabama, Coll Med, Ctr Lung Biol, Mobile, AL 36688 USA ^[1] Celsion EGEN, Huntsville, AL 35806 USA ^[2] Univ S Alabama, Coll Med, Dept Internal Med, Mobile, AL 36688 USA ^[3] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA ^[4] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA ^[5]

关键词 Lung delivery Lipid nanoparticle Antisense oligonucleotide Pulmonary hypertension MicroRNA-145 Sugen5416/hypoxia

发布时间 2015-08-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Controlled Release

2015年210卷

67-75页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension

Journal of Controlled Release

相似文献

Journal of Controlled Release

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension

Journal of Controlled Release

相似文献

Journal of Controlled Release

相关期刊

检索历史清除